Mattock M B, Morrish N J, Viberti G, Keen H, Fitzgerald A P, Jackson G
Unit for Metabolic Medicine, United Medical School, Guy's Hospital, London, United Kingdom.
Diabetes. 1992 Jun;41(6):736-41. doi: 10.2337/diab.41.6.736.
Retrospective studies of patients with non-insulin-dependent diabetes mellitus (NIDDM) have suggested that microalbuminuria predicts early all-cause (mainly cardiovascular) mortality independently of arterial blood pressure. These findings have not been confirmed in prospective studies, and it is not known whether the predictive power of microalbuminuria is independent of other major cardiovascular risk factors. During 1985-1987, we examined a representative group of 141 nonproteinuric patients with NIDDM for the prevalence of coronary heart disease and several of its established and putative risk factors, including raised urinary albumin excretion (UAE) rate. Thirty-six patients had microalbuminuria (UAE 20-200 micrograms/min), and 105 had normal UAE (less than 20 micrograms/min). At follow-up, an average of 3.4 yr later, 14 patients had died. There was a highly significant excess mortality (chiefly from cardiovascular disease) among those with microalbuminuria (28%) compared to those without microalbuminuria (4%, P less than 0.001). In univariate survival analysis, significant predictors of all-cause mortality included microalbuminuria (P less than 0.001), hypercholesterolemia (P less than 0.01), hypertriglyceridemia (P less than 0.05), and preexisting coronary heart disease (P less than 0.05). The predictive power of microalbuminuria persisted after adjustment for the effects of other major risk factors (P less than 0.05). We conclude that microalbuminuria is a significant risk marker for mortality in NIDDM, independent of the other risk factors examined. Its presence can be regarded as an index of increased cardiovascular vulnerability and a signal for vigorous efforts at correction of known risk factors.
对非胰岛素依赖型糖尿病(NIDDM)患者的回顾性研究表明,微量白蛋白尿可独立于动脉血压预测早期全因(主要是心血管)死亡率。这些发现在前瞻性研究中尚未得到证实,并且尚不清楚微量白蛋白尿的预测能力是否独立于其他主要心血管危险因素。在1985年至1987年期间,我们对141名无蛋白尿的NIDDM患者进行了代表性研究,以调查冠心病及其一些已确定和假定的危险因素的患病率,包括尿白蛋白排泄(UAE)率升高。36名患者有微量白蛋白尿(UAE为20 - 200微克/分钟),105名患者的UAE正常(低于20微克/分钟)。在平均3.4年的随访后,有14名患者死亡。与无微量白蛋白尿的患者(4%)相比,微量白蛋白尿患者中存在极高的死亡率(主要死于心血管疾病)(28%,P<0.001)。在单变量生存分析中,全因死亡率的显著预测因素包括微量白蛋白尿(P<0.001)、高胆固醇血症(P<0.01)、高甘油三酯血症(P<0.05)和既往冠心病(P<0.05)。在调整其他主要危险因素的影响后,微量白蛋白尿的预测能力仍然存在(P<0.05)。我们得出结论,微量白蛋白尿是NIDDM患者死亡率的一个重要风险标志物,独立于所检查的其他危险因素。其存在可被视为心血管易损性增加的指标以及积极努力纠正已知危险因素的信号。